Viking shares fell on Phase 2 obesity pill data as tolerability issues surfaced, but William Blair says the stock's sell-off ...

Eli Lilly and Novo Nordisk are expected to price their new obesity pills in line with existing injections, as analysts cite ...

Analysts have set 12-month price targets for Rocket Companies, revealing an average target of $16.22, a high estimate of $25.00, and a low estimate of $14.00. Observing a 21.41% increase, the current ...

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $40.38, along with a high estimate of $41.00 and a low estimate of $39.00. Marking an ...

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $20.33, along with a high estimate of $27.00 and a low estimate of $17.00. A 10.64% drop is ...

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $12.65, with a ...

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $5.56, along ...

Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Extra Space ...

According to Benzinga Pro, ACI Worldwide's peer group average for short interest as a percentage of float is 13.39%, which means the company has less short interest than most of its peers. Did you ...

Howard Marks dissects market madness, separating price from value, and warns investors: fundamentals are fading while ...

Nvidia's China woes have major implications for tech ETFs as Beijing pressures firms to use domestic alternatives. Near-term ...

Analysts expect the Dublin, Ireland-based company to report quarterly earnings at 29 cents per share. James Hardie Industries ...